Global Nicotine Replacement Therapy for Smoking Cessation Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Nicotine Replacement Therapy for Smoking Cessation Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
NRT, or Nicotine Replacement Therapy, refers to a range of smoking cessation aids that are designed to help individuals quit smoking by providing them with controlled doses of nicotine. NRT products are available in various forms, such as nicotine gum, patches, lozenges, nasal sprays, and inhalers. These aids work by delivering nicotine to the body without the harmful toxins and chemicals found in tobacco smoke, thereby reducing withdrawal symptoms and cravings associated with quitting smoking.
Nicotine Replacement Therapy for Smoking Cessation report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Nicotine Replacement Therapy for Smoking Cessation market is projected to reach US$ 727.3 million in 2033, increasing from US$ 524 million in 2022, with the CAGR of 4.8% during the period of 2023 to 2033. Demand from Pharmacy and Supermarket are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Nicotine Replacement Therapy for Smoking Cessation industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Nicotine Replacement Therapy for Smoking Cessation key companies include Pfizer, Cipla, Novartis, GlaxoSmithKline, Johnson & Johnson, Philip Morris, Perrigo Company, Alkalon and Ventus Medical, etc. Pfizer, Cipla, Novartis are top 3 players and held % share in total in 2022.
Nicotine Replacement Therapy for Smoking Cessation can be divided into Sprays and Inhalers, Gums, Patches and Lozenges, etc. Sprays and Inhalers is the mainstream product in the market, accounting for % share globally in 2022.
Nicotine Replacement Therapy for Smoking Cessation is widely used in various fields, such as Pharmacy, Supermarket, Hospital and Other, etc. Pharmacy provides greatest supports to the Nicotine Replacement Therapy for Smoking Cessation industry development. In 2022, global % share of Nicotine Replacement Therapy for Smoking Cessation went into Pharmacy filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Nicotine Replacement Therapy for Smoking Cessation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Pfizer
Cipla
Novartis
GlaxoSmithKline
Johnson & Johnson
Philip Morris
Perrigo Company
Alkalon
Ventus Medical
Segment by Type
Sprays and Inhalers
Gums
Patches
Lozenges
Pharmacy
Supermarket
Hospital
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Nicotine Replacement Therapy for Smoking Cessation market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Nicotine Replacement Therapy for Smoking Cessation introduction, etc. Nicotine Replacement Therapy for Smoking Cessation Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Nicotine Replacement Therapy for Smoking Cessation market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Nicotine Replacement Therapy for Smoking Cessation report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Nicotine Replacement Therapy for Smoking Cessation market is projected to reach US$ 727.3 million in 2033, increasing from US$ 524 million in 2022, with the CAGR of 4.8% during the period of 2023 to 2033. Demand from Pharmacy and Supermarket are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Nicotine Replacement Therapy for Smoking Cessation industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Nicotine Replacement Therapy for Smoking Cessation key companies include Pfizer, Cipla, Novartis, GlaxoSmithKline, Johnson & Johnson, Philip Morris, Perrigo Company, Alkalon and Ventus Medical, etc. Pfizer, Cipla, Novartis are top 3 players and held % share in total in 2022.
Nicotine Replacement Therapy for Smoking Cessation can be divided into Sprays and Inhalers, Gums, Patches and Lozenges, etc. Sprays and Inhalers is the mainstream product in the market, accounting for % share globally in 2022.
Nicotine Replacement Therapy for Smoking Cessation is widely used in various fields, such as Pharmacy, Supermarket, Hospital and Other, etc. Pharmacy provides greatest supports to the Nicotine Replacement Therapy for Smoking Cessation industry development. In 2022, global % share of Nicotine Replacement Therapy for Smoking Cessation went into Pharmacy filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Nicotine Replacement Therapy for Smoking Cessation market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Pfizer
Cipla
Novartis
GlaxoSmithKline
Johnson & Johnson
Philip Morris
Perrigo Company
Alkalon
Ventus Medical
Segment by Type
Sprays and Inhalers
Gums
Patches
Lozenges
Segment by Application
Pharmacy
Supermarket
Hospital
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Nicotine Replacement Therapy for Smoking Cessation market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Nicotine Replacement Therapy for Smoking Cessation introduction, etc. Nicotine Replacement Therapy for Smoking Cessation Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Nicotine Replacement Therapy for Smoking Cessation market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.